{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:07:26Z","timestamp":1772276846796,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>The recurrence rate of common bile duct stones (CBDS) after removal has been reported to exceed 10% and no established pharmacologic treatment exists for the prevention of recurrent CBDS. Many studies indicated ursodeoxycholic acid (UDCA) has the potential to prevent the recurrence of CBDS. The aim of this systematic review is to evaluate the effects of UDCA for prevention of recurrence after common bile duct stones removal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>We will systematically screen all randomized controlled trials (RCTs) published through electronically and hand searching. The following search engines including Ovid Medline, EMBASE, Cochrane CENTRAL, Proquest, Scopus, Web of Science, Pubmed, the Chinese Biomedical Literature Database, the China National Knowledge Infrastructure, VIP Information, Wanfang Data. Supplementary sources will be searched including gray literature, conference proceedings, and potential identified publications in OpenGrey.eu and Google Scholar databases. Two reviewers will independently conduct the trial inclusion, data extraction and assess the quality of studies. The recurrence rate of CBDS will be assessed as the primary outcomes. The adverse event that required discontinuation of UDCA intervention and the drop-outs (lost to follow-up) before the end of the study will be measured as secondary outcomes. Methodological quality will be evaluated according to the Cochrane risk of bias. All analyses will be applied by RevMan (version 5.3).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This systemic review and meta-analysis will evaluate the effects of UDCA for prevention of recurrence after CBDS removal in RCTs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our study will provide evidence to judge whether UDCA is an effective intervention to prevent the recurrence after CBDS removal.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013086","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T21:26:40Z","timestamp":1541539600000},"page":"e13086","source":"Crossref","is-referenced-by-count":12,"title":["Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence"],"prefix":"10.1097","volume":"97","author":[{"given":"Xun","family":"Chen","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Gastroenterology, Dongfang Hospital of Beijing University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ru","family":"Yan","sequence":"additional","affiliation":[{"name":"Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine"},{"name":"Department of Gastroenterology, Dongfang Hospital of Beijing University of Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-2007-1010576","article-title":"Prospective evaluation of the use of endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy","volume":"24","author":"Neuhaus","year":"1992","journal-title":"Endoscopy"},{"key":"R2-20230915","first-page":"381","article-title":"Preoperative bilirubin, alkaline phosphatase and amylase levels as predictors of common duct stones","volume":"154","author":"Saltzstein","year":"1982","journal-title":"Surg Gynecol Obstet"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/archsurg.1980.01380090080019","article-title":"Preoperative evaluation of the risk of common bile duct stones","volume":"115","author":"Lacaine","year":"1980","journal-title":"Arch Surg"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9610(99)80249-9","article-title":"Predicting common bile duct lithiasis: determination and prospective validation of a model predicting low risk","volume":"170","author":"Houdart","year":"1995","journal-title":"Am J Surg"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/gut.37.4.576","article-title":"Selective preoperative endoscopic retrograde cholangiography with sphincterotomy avoids bile duct exploration during laparoscopic cholecystectomy","volume":"37","author":"Welbourn","year":"1995","journal-title":"Gut"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00464-008-9883-2","article-title":"How reliable is intraoperative cholangiography as a method for detecting common bile duct stones?: a prospective population-based study on 1171 patients","volume":"23","author":"Videhult","year":"2009","journal-title":"Surg Endosc"},{"key":"R7-20230915","first-page":"1","article-title":"Evidence-based clinical practice guidelines for cholelithiasis 2016","volume":"52","author":"Tazuma","year":"2016","journal-title":"J Gastroenterol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhep.2016.03.005","article-title":"Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"R9-20230915","first-page":"1","article-title":"Updated guideline on the management of common bile duct stones (CBDS)","author":"Williams","year":"2017","journal-title":"Gut"},{"key":"R10-20230915","first-page":"15","article-title":"Recurrence of common bile duct stones after endoscopic proceduresin relation to papillary function","volume":"28","author":"Yasuda","year":"2007","journal-title":"Tan to Sui (J Biliary Tract Pancreas)"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.dld.2007.11.012","article-title":"Combination of endoprostheses and oral ursodeoxycholic acid or placeboin the treatment of difficult to extract common bile duct stones","volume":"40","author":"Katsinelos","year":"2008","journal-title":"Dig LiverDis"},{"key":"R12-20230915","first-page":"621","article-title":"Preventing the recurrence of common bile duct calculi following endoscopic papillotomy with ursodeoxycholic acid","volume":"28","author":"Swobodnik","year":"1990","journal-title":"Zeitschrift Gastroenterol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jhbp.316","article-title":"Ursodeoxycholic acid after bile duct stone removal and risk factors for recurrence: a randomized trial","volume":"23","author":"Yamamoto","year":"2016","journal-title":"J Hepatobiliary-Pancreat Sci"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/eci.12058","article-title":"Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol","volume":"43","author":"Wang","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cgh.2013.11.031","article-title":"Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials","volume":"12","author":"Caroline","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-230X-13-155","article-title":"Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity","volume":"13","author":"Buryova","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:09:10Z","timestamp":1694812150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00034"}},"subtitle":["A systematic review and meta-analysis of randomized controlled trials"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":18,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013086","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}